Products
Pipeline
Our pipeline is powered by end-to-end research and development capabilities. This commitment to operational excellence and patient safety ensures we consistently produce the highest quality medicines
Product | Indication | Preclinical | IND | Phase 1 | Phase 2 | Phase 3 Pivotal BA/BE | NDA Submission |
---|---|---|---|---|---|---|---|
ALM003 | Depression | ||||||
ALM008 | Bipolar Disorder | ||||||
ALM009 | Depression/Anxiety | ||||||
ALM013 | Anxiety | ||||||
ALM014 | Depression |